白云山(00874.HK)子公司产品获签发澳门药品注册证书

阿斯达克财经
10 Jan

白云山(00874.HK) 公布,近日控股子公司光华药业收到澳门政府药物监督管理局通知,旗下非处方中成药产品小柴胡颗粒及柴胡颗粒(无糖型)两品种,已获签发《中成药注册证明书》。该产品将由光华药业授权德圣堂药物产品出入口及批发商号在澳门地区销售,白云山夤期有助于光华药业扩展境外市场业务。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-09 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10